

Aridis Pharmaceuticals Inc (NASDAQ: ARDS) shares are gaining after announcing positive European Medicines Agency feedback on its proposed single confirmatory...
You can purchase shares of ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. (OTCEM:ARDS) through any online brokerage.
There are no as such competitors for ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc..
There is no analysis for ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. to provide a consensus price target.
The stock price for ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. (OTCEM: ARDS) is $0.0002 last updated November 10, 2025 at 8:36 AM EST.
There are no upcoming dividends for ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc..
ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc..
ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.
Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.